losartan has been researched along with Microglossia in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diestro, JDB | 1 |
| Sedano, LSP | 1 |
| Reyes, NGD | 1 |
| San Jose, MCZ | 1 |
| Bridges, MJ | 1 |
| Kelly, CA | 1 |
2 other studies available for losartan and Microglossia
| Article | Year |
|---|---|
Hemilingual Angioedema after Thrombolysis in a Patient on an Angiotensin II Receptor Blocker.
Topics: Administration, Intravenous; Angioedema; Angiotensin II Type 1 Receptor Blockers; Fibrinolytic Agent | 2019 |
Raynaud's phenomenon affecting the tongue of a patient with scleroderma.
Topics: Female; Humans; Losartan; Middle Aged; Raynaud Disease; Scleroderma, Systemic; Tongue Diseases; Vaso | 2002 |